This application requests continued support for the tri-institutional Medical Scientist Training Program (MSTP) at Stony Brook University, Cold Spring Harbor Laboratory and Brookhaven National Laboratory. Continuously supported by the NIGMS since 1992, our MSTP has almost a 40-year history of training physician-scientists, many of whom have gone on to make important discoveries and become leaders in biomedical research at academic medical centers across the country. Of our 111 graduates thus far, 43% are still in training, all in strong academic medical programs. Of the remaining graduates, 71% have academic faculty positions, many of which are highly prestigious, or are affiliated with university hospitals, NIH, or biotechnology / pharmaceutical groups, and another 11% are primarily clinical but contribute as educators and have academic connections. The goal of the program is to provide a rigorous training path that creates and fosters a physician-scientist mentality and a culture that imbues trainees with the tools, motivation, identity, and drive to pursue careers in academic medicine. Students are exposed to both clinical and basic scientific activities throughout their training, reinforcing the special nature of this program. Core courses unique to our MSTP include monthly seminar / dinners with both internal and external physician-scientist speakers, and a monthly journal club ? clinical pathological correlation dinner-evening that combines basic science with clinical applications in an active-learning manner. Our students participate in mini-courses in our unique Alan Alda Center for Communicating Science. PhD degrees are offered in a wide range of disciplines with the students being guided to undertake high-quality basic / translational science training to address problems relevant to human health. Since the last review, there have been many changes at SBU including (i) the recruitment of new MD and MD-PhD physician-scientists as Chairs of the major clinical departments and (iv) a $450M construction of a Cancer Center and Children?s Hospital. The MSTP has grown from 40 students 10 years ago to 58 at the last renewal and now 63, annual institutional support to the MSTP has correspondingly increased, the applicant pool size has remained stable, and both applicant and matriculant quality have increased substantially. In 2017/18, we matriculated 7 students (and we typically add another student from the existing medical school class). Many of our students hold individual NRSAs, publish high-impact articles, and have received a variety of honors, both intra- and extramurally. Overall time-to- graduation has averaged 8.05 years over the past decade. On average, MSTPs receive support for 25% of the funding years; in this application, we thus request that level of support, i.e. 16 lines. We are committed to the training of exceptional physician-scientists, which renewed funding will greatly facilitate.

Public Health Relevance

The Stony Brook School of Medicine is committed to the training of future physician-scientists to address a pressing need for individuals who can undertake scientific discovery with direct relevance to human health. Trainees undertake a rigorous academic program that culminates in the awarding of an MD and a PhD and many go on to become leaders in biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM008444-29
Application #
9854148
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
1992-07-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
29
Fiscal Year
2020
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Schneider, Michael; Kumar, Vivek; Nordstrøm, Lars Ulrik et al. (2018) Inhibition of Delta-induced Notch signaling using fucose analogs. Nat Chem Biol 14:65-71
Werneburg, Glenn T; Thanassi, David G (2018) Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella. EcoSal Plus 8:
Miyauchi, Jeremy Tetsuo; Caponegro, Michael D; Chen, Danling et al. (2018) Deletion of Neuropilin 1 from Microglia or Bone Marrow-Derived Macrophages Slows Glioma Progression. Cancer Res 78:685-694
Werneburg, Glenn T; Kongnyuy, Michael; Halpern, Daniel M et al. (2018) Effects of Focal vs Total Cryotherapy and Minimum Tumor Temperature on Patient-reported Quality of Life Compared With Active Surveillance in Patients With Prostate Cancer. Urology 113:110-118
Werneburg, Glenn T; Kongnyuy, Michael; Halpern, Daniel M et al. (2018) Patient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillance. Prostate Cancer Prostatic Dis 21:355-363
Rubin, Ewelina; Werneburg, Glenn T; Pales Espinosa, Emmanuelle et al. (2016) Identification and characterization of peptidases secreted by quahog parasite unknown (QPX), the protistan parasite of hard clams. Dis Aquat Organ 122:21-33
Huculeci, Radu; Cilia, Elisa; Lyczek, Agatha et al. (2016) Dynamically Coupled Residues within the SH2 Domain of FYN Are Key to Unlocking Its Activity. Structure 24:1947-1959
Park, Juwon; Wysocki, Robert W; Amoozgar, Zohreh et al. (2016) Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med 8:361ra138
Bhagwat, Anand S; Roe, Jae-Seok; Mok, Beverly Y L et al. (2016) BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements. Cell Rep 15:519-530
Li, Feng-Qian; Chen, Xingwang; Fisher, Cody et al. (2016) BAR Domain-Containing FAM92 Proteins Interact with Chibby1 To Facilitate Ciliogenesis. Mol Cell Biol 36:2668-2680

Showing the most recent 10 out of 155 publications